Oncogenic pathway signatures in human cancers as a guide to targeted therapies

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature

• Publication date

  2006-01-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature04296PMID 16273092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis

  2005cited by this paper
• A module map showing conditional activity of expression modules in cancer

  2004cited by this paper
• Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression.

  2004cited by this paper
• Gene expression phenotypic models that predict the activity of oncogenic pathways

  2003cited by this paper
• A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

  2003cited by this paper
• A molecular signature of metastasis in primary solid tumors

  2003cited by this paper
• Distinct gene expression phenotypes of cells lacking Rb and Rb family members.

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

  2003cited by this paper
• Gene expression predictors of breast cancer outcomes.

  2003cited by this paper
• A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer.

  2003cited by this paper
• DNA microarrays in clinical oncology.

  2002cited by this paper
• Predicting the clinical status of human breast cancer by using gene expression profiles

  2001cited by this paper
• c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

  2001cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Molecular abnormalities in lung cancer.

  1998cited by this paper
• Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.

  1997cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Results of rectocele repair

  1995cited by this paper
• Culture systems for study of human mammary epithelial cell proliferation, differentiation and transformation.

  1993cited by this paper
• Comparison of MTT, XTT, and a novel tetrazolium compound MTS for in vitro proliferation and chemosensitivity assays

  1992cited by this paper
• Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.

  1991cited by this paper
• Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture.

  1991cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper

• BCL2A1high CD8+ T Cells Are a Survival-Associated Predictor of Immune Checkpoint Blockade Response in Lung Adenocarcinoma

  2026cites this paper
• Prototype-driven fusion of pathology and spatial transcriptomics for interpretable survival prediction

  2026cites this paper
• TGFβ signaling promotes cell cycle progression and resistance to the CDK4/6 inhibitor palbociclib through SOX4 transcriptional modulation in breast cancer cells

  2026cites this paper
• Insights from Genomic Sequencing of Preclinical Breast Cancer Models Establish Human Parallels to Increase Therapeutic Applicability.

  2026cites this paper
• Unsupervised Identification of Cancer Attractor States through the Lens of Embryonic Origin and Cancer Hallmarks

  2026cites this paper
• Octa-Cationic Porphyrin-Functionalized Biocompatible Nanocomposite: A Promising Candidate for Enhanced Combinatorial Photodynamic and Photothermal Tumor Therapy.

  2025cites this paper
• Aberrant DNA methylation and overexpression of NR0B1 are prognostic biomarkers in KEAP1-mutant lung adenocarcinomas

  2025cites this paper
• Learning Invariant Graph Representations for Cox Survival Modeling under Distribution Shifts

  2025cites this paper
• Apoptosis-inducing factor (AIF) at the crossroad of cell survival and cell death: implications for cancer and mitochondrial diseases

  2025cites this paper
• Lipid peroxidation and type I interferon coupling fuels pathogenic macrophage activation causing tuberculosis susceptibility

  2025cites this paper
• Heterogeneity of acute myeloid leukemia patients explored through single-cell and single-sample gene regulatory networks.

  2025cites this paper
• A Cross-Species and Sex-Specific Meta-Analysis of Transcriptomic Studies of Pulmonary Hypertension.

  2025cites this paper
• Exploration of genes related to the development of cancer of unknown primary

  2025cites this paper
• Prognostic significance of IL11RA and its methylation in lung adenocarcinoma

  2025cites this paper
• DNA damaging agents boost the transcription of endothelin A receptor in high-grade serous ovarian cancer

  2025cites this paper
• Claudin and Rab proteins are key molecular components involved in coccidiosis resistance in Portuguese Merino sheep

  2025cites this paper
• Tubulin epsilon and delta complex 2 enhances malignancy in non-small cell lung cancer by activating the hedgehog signaling pathway to promote tumor cell stemness.

  2025cites this paper
• Gene Signature-Based Drug Screening Reveals Ponatinib Enhances Immunotherapy Efficacy in Triple-Negative Breast Cancer by Reversing MDSC-Mediated Immunosuppressive Tumor Microenvironment

  2025cites this paper
• Activation of RAS/MEK/ERK signalling drives biliary differentiation in primary liver cancer

  2025cites this paper
• Disulfidptosis-associated gene signature predicts prognosis and radioresistance in NSCLC

  2025cites this paper
• Demystifying programmed cell death in lung adenocarcinoma: combined prognostic model construction

  2025cites this paper
• System analysis links SMARCD3 regulons to growth signaling and MEK inhibitor response in everolimus-resistant ER+ breast cancer cells

  2025cites this paper
• SRC at the Crossroads of KRAS Inhibitor Resistance: Mechanisms and Therapeutic Opportunities.

  2025cites this paper
• Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma

  2025cites this paper
• Single-cell RNA sequencing integrated with bulk RNA sequencing analysis identifies a tumor immune microenvironment-related lncRNA signature in lung adenocarcinoma

  2024cites this paper
• Cost and time-efficient construction of a 3′-end mRNA library from unpurified bulk RNA in a single tube

  2024cites this paper
• Region‐specific DNA hydroxymethylation along the malignant progression of IDH‐mutant gliomas

  2024cites this paper
• Anoikis-related gene signature is associated with immune infiltration and predicts the prognosis of non-small cell lung cancer

  2024cites this paper
• The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastoma

  2024cites this paper
• Genetic and epigenetic alterations in human cancers

  2024cites this paper
• The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy

  2024cites this paper
• Lipid Peroxidation and Type I Interferon Coupling Fuels Pathogenic Macrophage Activation Causing Tuberculosis Susceptibility

  2024cites this paper
• Molecular docking of selected steroid compounds from Hydrilla Verticillata on human Ros1 kinase receptor

  2024cites this paper
• Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL–mediated leukemia

  2024cites this paper
• DeepFusionCDR: Employing Multi-Omics Integration and Molecule-Specific Transformers for Enhanced Prediction of Cancer Drug Responses

  2024cites this paper
• Boosting predictive models and augmenting patient data with relevant genomic and pathway information

  2024cites this paper
• An analysis of the prognostic role of reactive oxygen species‐associated genes in breast cancer

  2024cites this paper
• TDP2 is a regulator of estrogen-responsive oncogene expression

  2024cites this paper
• Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC paralogs.

  2024cites this paper
• Deciphering the heterogeneity dominated by tumor-associated macrophages for survival prognostication and prediction of immunotherapy response in lung adenocarcinoma

  2024cites this paper
• Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuit

  2024cites this paper
• Nup210 promotes colorectal cancer progression by regulating nuclear plasma transport.

  2024cites this paper
• A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers

  2024influential citation
• miRNA in Machine-Learning-Based Diagnostics of Oral Cancer

  2024cites this paper
• UL16‑binding protein 1 is a significant prognostic and diagnostic marker for breast cancer

  2024cites this paper
• Insight into mammary gland development and tumor progression in an E2F5 conditional knockout mouse model

  2024cites this paper
• Up-regulated transcriptional regulators in mutant RAS gene signatures: a time-resolved multi-omics study in generic epithelial cell models

  2024cites this paper
• Machine learning-based integration develops an immunogenic cell death-derived lncRNA signature for predicting prognosis and immunotherapy response in lung adenocarcinoma

  2024cites this paper
• Pan-Cancer, Genome-Scale Metabolic Network Analysis of over 10,000 Patients Elucidates Relationship between Metabolism and Survival

  2024cites this paper
• Pathway Activation Analysis for Pan-Cancer Personalized Characterization Based on Riemannian Manifold

  2024cites this paper
• Feature Network Methods in Machine Learning and Applications

  2024cites this paper
• Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling

  2024cites this paper
• Trichosanthin elicits antitumor activity via MICU3 mediated mitochondria calcium influx

  2024cites this paper
• TDP 2 modulates the expression of estrogen-responsive oncogenes

  2024cites this paper
• Comprehensive analysis of consensus molecular subtypes for ovarian cancer from bulk to single-cell perspectives

  2024cites this paper
• Machine Learning of Three-Dimensional Protein Structures to Predict the Functional Impacts of Genome Variation

  2024cites this paper
• TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling

  2024cites this paper
• The Role of tRNA-Centered Translational Regulatory Mechanisms in Cancer

  2023cites this paper
• Establishment of bladder cancer spheroids and cultured in microfluidic platform for predicting drug response

  2023cites this paper
• A Bayesian noisy logic model for inference of transcription factor activity from single cell and bulk transcriptomic data

  2023cites this paper
• A multiomic investigation of lung adenocarcinoma molecular subtypes

  2023cites this paper
• High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma

  2023cites this paper
• Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes

  2023cites this paper
• MIRS: An AI scoring system for predicting the prognosis and therapy of breast cancer.

  2023cites this paper
• Machine learning estimated probability of relapse in early-stage non-small-cell lung cancer patients with aneuploidy imputation scores and knowledge graph embeddings

  2023cites this paper
• PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer

  2023cites this paper
• Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma

  2023cites this paper
• TPX2 expression promotes sensitivity to dasatinib in breast cancer by activating the YAP transcriptional signaling

  2023cites this paper
• Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC paralogs

  2023cites this paper
• Prognostic and immune correlation analysis of mitochondrial autophagy and aging-related genes in lung adenocarcinoma

  2023influential citation
• MAGI1 Prevents Senescence and Promotes the DNA Damage Response in ER+ Breast Cancer

  2023cites this paper
• Routine Clinically Detected Increased ROS1 Transcripts Are Related With ROS1 Expression by Immunohistochemistry and Associated With EGFR Mutations in Lung Adenocarcinoma

  2023cites this paper
• CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients

  2023cites this paper
• Synergy between imputed genetic pathway and clinical information for predicting recurrence in early stage non-small cell lung cancer

  2023cites this paper
• Sodium orthovanadate exhibits anti-angiogenic, antiapoptotic and blood glucose-lowering effect on colon cancer associated with diabetes

  2023cites this paper
• Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression

  2023cites this paper
• Methylglyoxal: a novel upstream regulator of DNA methylation

  2023cites this paper
• Machine learning-based integration of CD8 T cell-related gene signatures for comprehensive prognostic assessment in lung adenocarcinoma

  2023cites this paper
• Optimisation Models for Pathway Activity Inference in Cancer

  2023cites this paper
• A compilation of bioinformatic approaches to identify novel downstream targets for the detection and prophylaxis of cancer.

  2023cites this paper
• IDriveGenes: Cancer Driver Genes Prediction Using Machine Learning

  2023cites this paper
• Validating a Macrophage Marker Gene Signature (MMGS) in Lung Adenocarcinoma Prognosis and Response to Immunotherapy

  2023cites this paper
• Glutamine metabolism in breast cancer and possible therapeutic targets.

  2023cites this paper
• An Entropy-Based Directed Random Walk for Cancer Classification Using Gene Expression Data Based on Bi-Random Walk on Two Separated Networks

  2023cites this paper
• NONHSAT021545/miR-330-3p/EREG: A Cooperative Axis in Breast Cancer Prognosis and Treatment

  2023cites this paper
• A Bayesian Noisy Logic Model for Inference of Transcription Factor Activity from Single Cell and Bulk Transcriptomic Data

  2023cites this paper
• Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma

  2023cites this paper
• Gene Expression Profiles in Cancers and Their Therapeutic Implications.

  2023cites this paper
• Systematic assessment of prognostic molecular features across cancers

  2023cites this paper
• Cytosolic EpCAM cooperates with H-Ras to regulate epithelial to mesenchymal transition through ZEB1

  2023cites this paper
• An intrinsic purine metabolite AICAR blocks lung tumour growth by targeting oncoprotein mucin 1

  2023cites this paper
• MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas

  2023cites this paper
• Modulating β-catenin/BCL9 interaction with cell-membrane-camouflaged carnosic acid to inhibit Wnt pathway and enhance tumor immune response

  2023cites this paper
• MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes

  2022cites this paper
• Low expression of MYCN promotes cisplatin resistance by suppressing cisplatin-induced apoptosis in epithelial ovarian cancer.

  2022cites this paper
• RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma

  2022cites this paper
• Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer

  2022cites this paper
• Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinoma

  2022cites this paper
• Sublethal cytochrome c release generates drug-tolerant persister cells.

  2022cites this paper
• Oxysterol derivatives Oxy186 and Oxy210 inhibit WNT signaling in non-small cell lung cancer

  2022cites this paper